Merge Healthcare (MRGE) Receiving Somewhat Favorable Media Coverage, Study Shows

Media stories about Merge Healthcare (NASDAQ:MRGE) have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Merge Healthcare earned a news sentiment score of 0.14 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 45.755263168155 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

TRADEMARK VIOLATION NOTICE: “Merge Healthcare (MRGE) Receiving Somewhat Favorable Media Coverage, Study Shows” was reported by Markets Daily and is the property of of Markets Daily. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://www.themarketsdaily.com/2017/11/21/merge-healthcare-mrge-receiving-somewhat-favorable-media-coverage-study-shows.html.

About Merge Healthcare

Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. The Company operates through two segments: Merge Healthcare and Merge DNA. The Company’s Merge Healthcare segment markets, sells and implements interoperability, imaging and clinical solutions to healthcare providers.

Insider Buying and Selling by Quarter for Merge Healthcare (NASDAQ:MRGE)

Receive News & Ratings for Merge Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merge Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply